STOCK:SPY

Bath & Body Works Beats Q4 Estimates but Forecasts Sales Decline in 2026

Font: Financial Modeling Prep  • Mar 04, 2026

Market Chart

Bath & Body Works, Inc. (NYSE: BBWI) reported fourth-quarter results that topped analyst expectations, although the company projected weaker sales for fiscal 2026 as it continues executing a transformation strategy. Shares rose more than 4% intra-day Wednesday following the report.

The retailer posted adjusted earnings per share of $2.05 for the quarter ended January 31, exceeding the $1.75 consensus estimate by $0.30. Revenue reached $2.7 billion, surpassing expectations of $2.6 billion but declining 2% from $2.8 billion in the prior-year quarter.

The company said the quarter benefited from faster product innovation and the earlier-than-planned launch of its products on Amazon.

For fiscal 2026, Bath & Body Works expects adjusted earnings per share between $2.40 and $2.65. The midpoint of $2.53 is below the analyst consensus estimate of $2.59. Net sales are projected to decline between 4.5% and 2.5% compared with fiscal 2025 revenue of $7.3 billion.

For the first quarter, the company forecasts adjusted earnings per share between $0.24 and $0.30, compared with $0.49 in the first quarter of 2025. Net sales for the period are expected to decline between 6% and 4%.

For fiscal 2025, Bath & Body Works reported adjusted earnings per share of $3.21, compared with $3.29 in 2024. Annual net sales totaled $7.3 billion, down slightly by 0.2% year over year.

Market Overview
BHAT
Fujian Blue Hat Interactive Entertainment Technology Ltd.
$0.04
27.18%
TPET
Trio Petroleum Corp.
$1.59
87.28%
MOBX
Mobix Labs, Inc.
$0.87
5.61%
QNCX
Quince Therapeutics, Inc.
$0.11
5.19%
GXAI
Gaxos.ai Inc.
$1.81
45.97%
IBO
Impact BioMedical Inc.
$0.64
55.46%
TZA
Direxion Daily Small Cap Bear 3X ETF
$6.54
5.65%
NVDA
NVIDIA Corporation
$183.34
0.16%
UOKA
MDJM Ltd
$0.08
9.92%
TQQQ
ProShares - UltraPro QQQ
$49.80
-0.92%